Cargando…
Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence
INTRODUCTION: Menopausal hormone therapy (HT) is typically withheld from breast cancer survivors because of concerns about risk for recurrence. Our objectives were to estimate the effects of HT on recurrence in breast cancer survivors and to examine the reliability of these estimates. METHODS: In a...
Autores principales: | Col, Nananda F, Kim, Jung A, Chlebowski, Rowan T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175064/ https://www.ncbi.nlm.nih.gov/pubmed/15987460 http://dx.doi.org/10.1186/bcr1035 |
Ejemplares similares
-
Menopausal hormone therapy after breast cancer
por: Colditz, Graham A
Publicado: (2005) -
Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: Findings from the Women’s Health Initiative
por: Al-Rousan, Tala, et al.
Publicado: (2018) -
Vitamin D and breast cancer: interpreting current evidence
por: Chlebowski, Rowan T
Publicado: (2011) -
Prescribing menopausal hormone therapy: an evidence-based approach
por: Sood, Richa, et al.
Publicado: (2014) -
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
Publicado: (2019)